Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 41,667 shares of the firm's stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $41.65, for a total transaction of $1,735,430.55. Following the sale, the chairman now owns 82,548 shares of the company's stock, valued at $3,438,124.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Progyny Stock Performance
Shares of NASDAQ:PGNY opened at $44.32 on Friday. The company has a market cap of $4.08 billion, a PE ratio of 96.35, a price-to-earnings-growth ratio of 11.08 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32. The firm has a 50 day simple moving average of $31.18 and a 200 day simple moving average of $37.49.
Get Progyny alerts:Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04. The business had revenue of $195.00 million during the quarter, compared to the consensus estimate of $190.51 million. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The firm's quarterly revenue was up 51.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. On average, equities analysts predict that Progyny, Inc. will post 0.18 earnings per share for the current year.
Institutional Investors Weigh In On Progyny
Hedge funds have recently made changes to their positions in the company. American Century Companies Inc. lifted its position in Progyny by 407.4% in the 4th quarter. American Century Companies Inc. now owns 2,323,001 shares of the company's stock worth $116,963,000 after buying an additional 1,865,151 shares in the last quarter. Baillie Gifford & Co. lifted its position in Progyny by 337,578.8% in the 1st quarter. Baillie Gifford & Co. now owns 1,337,208 shares of the company's stock worth $68,732,000 after buying an additional 1,336,812 shares in the last quarter. Riverbridge Partners LLC lifted its position in Progyny by 87.7% in the 1st quarter. Riverbridge Partners LLC now owns 1,525,055 shares of the company's stock worth $78,388,000 after buying an additional 712,722 shares in the last quarter. Wafra Inc. lifted its position in Progyny by 64.1% in the 1st quarter. Wafra Inc. now owns 1,252,197 shares of the company's stock worth $64,363,000 after buying an additional 489,179 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its position in Progyny by 13.3% in the 2nd quarter. Clearbridge Investments LLC now owns 3,652,887 shares of the company's stock worth $106,116,000 after buying an additional 429,385 shares in the last quarter. Hedge funds and other institutional investors own 82.51% of the company's stock.Progyny Company Profile
(Get Rating)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Read More
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.